The MarketWatch News Department was not involved in the creation of this content. TUSCON, Ariz., March 09, 2026 (GLOBE NEWSWIRE) -- The mechanism of action of mRNA vaccines goes far beyond harnessing ...

The biotech company a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.

The biotech company said the FDA won't review its flu vaccine, in the latest hit to mRNA development As COVID-19 vaccine sales dwindle, pressure on Moderna to grow its business has increased.

Vinay Prasad, a top regulator at the FDA, did not detail the data in the internal memo that led to the conclusion Pfizer and BioNTech developed the COVID-19 vaccine Comirnaty. Shares of Moderna and ...